373461004: Prokinetic Agent (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
agent procinétique	Is a	Gastrointestinal agent (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Dexpanthenol agent	Is a	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Prokinetic Agent	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Dexpanthenol	Is a	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing trimethobenzamide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing cisapride (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Domperidone(motility) [see chapter d for preparations]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Domperidone [nausea]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely domperidone 10 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Domperidone 5mg/5mL suspension (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely domperidone 30 milligram/1 each conventional release rectal suppository (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Metoclopramide hydrochloride product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Metoclopramide hydrochloride 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely metoclopramide hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
chlorhydrate de métoclopramide 5 mg/mL, ampoule de 2 mL de solution pour injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Metoclopramide hydrochloride 15mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Metoclopramide hydrochloride 15mg m/r capsule (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Metoclopramide hydrochloride 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Metoclopramide hydrochloride 1mg/mL pediatric oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
chlorhydrate de métoclopramide 5 mg/mL, fiole de 20 mL pour injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Metoclopramide hydrochloride 5mg/5mL s/f oral solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely cisapride 10 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely cisapride (as cisapride monohydrate) 1 milligram/1 milliliter conventional release oral suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Cisapride 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing domperidone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing metoclopramide in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Metoclopramide-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Trimethobenzamide hydrochloride 250 mg capsule (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely trimethobenzamide hydrochloride 100 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Trimethobenzamide hydrochloride 100 mg/2% suppository	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Trimethobenzamide hydrochloride 200 mg/2% suppository	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Trimethobenzamide hydrochloride 100 mg/mL intramuscular solution(substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Trimethobenzamide hydrochlor 100mg/mL injection (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Metoclopramide hydrochloride 5mg/mL infusion solution ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Trimethobenzamide hydrochloride 100mg/mL bar	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Cisapride 1mg/mL suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Trimethobenzamide hydrochlor 100mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Trimethobenzamide hydrochlor 200mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Benzocaine + trimethobenzamide hydrochlor 2%ww/100mg suppositories	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Metoclopramide-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely domperidone (as domperidone maleate) 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Paracetamol+metoclopramide 500mg/5mg tablet (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Metoclopramide hydrochloride 5 mg and paracetamol 500 mg effervescent powder for oral suspension sachet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing benzocaine and trimethobenzamide hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing aspirin and metoclopramide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing metoclopramide and paracetamol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing domperidone maleate and paracetamol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Trimethobenzamide hydrochloride 300 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing trimethobenzamide hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely cisapride (as cisapride monohydrate) 1 milligram/1 milliliter conventional release oral suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Metoclopramide (as metoclopramide hydrochloride) 10 mg orodispersible tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)
Metoclopramide (as metoclopramide hydrochloride) 5 mg orodispersible tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	agent procinétique	Inferred relationship	Existential restriction modifier (core metadata concept)

Reference Sets

Concept inactivation indicator attribute value reference set (foundation metadata concept)

SAME AS association reference set (foundation metadata concept)

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1198760018	Prokinetic Agent (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1211933017	Prokinetic Agent	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1198760018	Prokinetic Agent (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1211933017	Prokinetic Agent	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
190081000077118	agent procinétique	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
190081000077118	agent procinétique	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module